Sangamo BioSciences, Inc. has signed a collaborative research agreement with Procter & Gamble Pharmaceuticals. Under the terms of the agreement, Sangamo will provide specific Universal GeneTools to P&G Pharmaceuticals for use in their internal research and validation programs. Financial terms were not disclosed. “Sangamo is pleased to provide P&G Pharmaceuticals with our engineered transcription factors Read more about Sangamo And Procter & Gamble Sign Collaborative Research Agreement[…]